Evidence map›Paper›PMID 17028241›Full record

ArticleEukaryotic cell2006

Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.

Meredith T Morris, Courtney DeBruin, Zhaoqing Yang, Jeremy W Chambers, Kerry S Smith, James C Morris

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Enzymatic and Structural Characterization of theAntimicrobial agents and chemotherapy · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition.International journal for parasitology. Drugs and drug resistance · 2013
    Article
  13. Article
  14. Article
  15. Extra-glycosomal localisation of Trypanosoma brucei hexokinase 2.International journal for parasitology · 2012
    Article
  16. Article
  17. Article
  18. Article
  19. State of the art in African trypanosome drug discovery.Current topics in medicinal chemistry · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Meredith T MorrisDepartment of Genetics and Biochemistry, Clemson University, 214 Biosystems Research Complex, 51 New Cherry Street, Clemson, SC 29634, USA.
Courtney DeBruin
Zhaoqing Yang
Jeremy W Chambers
Kerry S Smith
James C Morris
Clemson University · USKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trypanosoma brucei expresses two hexokinases that are 98% identical, namely, TbHK1 and TbHK2. Homozygous null TbHK2-/- procyclic-form parasites exhibit an increased doubling time, a change in cell morphology, and, surprisingly, a twofold increase in cellular hexokinase activity. Recombinant TbHK1 enzymatic activity is similar to that of other hexokinases, with apparent Km values for glucose and ATP of 0.09 +/- 0.02 mM and 0.28 +/- 0.1 mM, respectively. The k(cat) value for TbHK1 is 2.9 x 10(4) min(-1). TbHK1 can use mannose, fructose, 2-deoxyglucose, and glucosamine as substrates. In addition, TbHK1 is inhibited by fatty acids, with lauric, myristic, and palmitic acids being the most potent (with 50% inhibitory concentrations of 75.8, 78.4, and 62.4 microM, respectively). In contrast to TbHK1, recombinant TbHK2 lacks detectable enzymatic activity. Seven of the 10 amino acid differences between TbHK1 and TbHK2 lie within the C-terminal 18 amino acids of the polypeptides. Modeling of the proteins maps the C-terminal tails near the interdomain cleft of the enzyme that participates in the conformational change of the enzyme upon substrate binding. Replacing the last 18 amino acids of TbHK2 with the corresponding residues of TbHK1 yields an active recombinant protein with kinetic properties similar to those of TbHK1. Conversely, replacing the C-terminal tail of TbHK1 with the TbHK2 tail inactivates the enzyme. These findings suggest that the C-terminal tail of TbHK1 is important for hexokinase activity. The altered C-terminal tail of TbHK2, along with the phenotype of the knockout parasites, suggests a distinct function for the protein.

Indexed as

Amino Acid SequenceAnimalsBase SequenceDNA, ProtozoanGene DeletionGenes, ProtozoanHexokinaseIsoenzymesKineticsMicrobodiesModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedProtein Structure, TertiaryRecombinant ProteinsSequence Homology, Amino AcidDNA, ProtozoanHexokinaseIsoenzymesRecombinant Proteins

Identifiers

PMID17028241
PMCPMC1694814
OpenAlexW2167642876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.